flucytosine has been researched along with Carcinoma in Situ in 1 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandalon, Z | 1 |
| Fusenig, NE | 1 |
| McCutcheon, J | 1 |
| Taichman, LB | 1 |
| Garlick, JA | 1 |
1 other study available for flucytosine and Carcinoma in Situ
| Article | Year |
|---|---|
Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia.
Topics: Antimetabolites; Carcinoma in Situ; Cell Culture Techniques; Cell Death; Cytosine Deaminase; Dose-Re | 2001 |